Plasma Neprilysin Levels in Patients with Polycystic Ovary Syndrome
ContextInsulin resistance has been detected in a majority of patients with polycystic ovary syndrome (PCOS). Elevated neprilysin levels are associated with insulin resistance. ObjectiveThe present study aims to investigate plasma neprilysin and its relationship with endocrine and metabolic character...
Gespeichert in:
| Veröffentlicht in: | Acta endocrinologica (Bucharest, Romania : 2005) Romania : 2005), 2022, Vol.18 (1), p.35-39 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 39 |
|---|---|
| container_issue | 1 |
| container_start_page | 35 |
| container_title | Acta endocrinologica (Bucharest, Romania : 2005) |
| container_volume | 18 |
| creator | Oz Gul, O |
| description | ContextInsulin resistance has been detected in a majority of patients with polycystic ovary syndrome (PCOS). Elevated neprilysin levels are associated with insulin resistance. ObjectiveThe present study aims to investigate plasma neprilysin and its relationship with endocrine and metabolic characteristics in patients with PCOS. Subjects and MethodsThirty-five premenopausal PCOS patients and 35 healthy volunteers of similar age were included in the study. Demographic characteristics, biochemical and hormonal findings and also plasma neprilysin levels were determined in these patients and healthy controls. ResultsIn our study, HOMA-IR values were significantly higher in PCOS patients (3.3 ± 1.8) compared with the controls [(1.6 ± 1), p |
| doi_str_mv | 10.4183/aeb.2022.35 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9365417</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2703415397</sourcerecordid><originalsourceid>FETCH-LOGICAL-c288t-aa8e1fb2e420041eb9f69e4b3efebbae5722b54e41c67af598689930408a71bc3</originalsourceid><addsrcrecordid>eNpVkF1LwzAYhYMobk6v_AO9FKQzn21yI8iYHzDcQAXvQpK9dZG0nU036b-3c0Pw6j3wHs55OAhdEjzmRLIbA3ZMMaVjJo7QkEjOUpxl78e_mqRYyXyAzmL8xFhITMgpGjChckE5H6LJIphYmuQZ1o0PXfRVMoMthJj0amFaD1Ubk2_frpJFHTrXxda7ZL41TZe8dNWyqUs4RyeFCREuDneE3u6nr5PHdDZ_eJrczVJHpWxTYySQwlLgFGNOwKoiU8AtgwKsNSBySq3gwInLclMIJTOpFMMcS5MT69gI3e5z1xtbwtL1aI0JugcvexxdG6__fyq_0h_1ViuWCU7yPuDqENDUXxuIrS59dBCCqaDeRE1zzDgRTO2s13ura-oYGyj-agjWu9l1P7veza6ZYD_3W3Wr</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2703415397</pqid></control><display><type>article</type><title>Plasma Neprilysin Levels in Patients with Polycystic Ovary Syndrome</title><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Oz Gul, O</creator><creatorcontrib>Oz Gul, O</creatorcontrib><description>ContextInsulin resistance has been detected in a majority of patients with polycystic ovary syndrome (PCOS). Elevated neprilysin levels are associated with insulin resistance. ObjectiveThe present study aims to investigate plasma neprilysin and its relationship with endocrine and metabolic characteristics in patients with PCOS. Subjects and MethodsThirty-five premenopausal PCOS patients and 35 healthy volunteers of similar age were included in the study. Demographic characteristics, biochemical and hormonal findings and also plasma neprilysin levels were determined in these patients and healthy controls. ResultsIn our study, HOMA-IR values were significantly higher in PCOS patients (3.3 ± 1.8) compared with the controls [(1.6 ± 1), p<0.01]. Plasma neprilysin levels were significantly higher in the PCOS group compared to the control group (1502.1 ± 1641.2 vs. 764.6 ± 562.6 pg/mL). There was no difference in plasma neprilysin levels when PCOS patients were classified as overweight-obesity (BMI≥25kg/m2) or non-obesity (BMI<25kg/m2). ConclusionOur findings revealed significantly higher levels for plasma neprilysin and HOMA-IR values in PCOS patients when compared to controls. No significant differences were noted between obese PCOS patients and non-obese PCOS patients in terms of plasma neprilysin levels.</description><identifier>ISSN: 1841-0987</identifier><identifier>EISSN: 1843-066X</identifier><identifier>DOI: 10.4183/aeb.2022.35</identifier><identifier>PMID: 35975244</identifier><language>eng</language><publisher>Romania: Carol Davila University Press</publisher><subject>General Endocrinology</subject><ispartof>Acta endocrinologica (Bucharest, Romania : 2005), 2022, Vol.18 (1), p.35-39</ispartof><rights>2021 Acta Endocrinologica (Buc) 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c288t-aa8e1fb2e420041eb9f69e4b3efebbae5722b54e41c67af598689930408a71bc3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365417/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365417/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,4010,27900,27901,27902,53766,53768</link.rule.ids></links><search><creatorcontrib>Oz Gul, O</creatorcontrib><title>Plasma Neprilysin Levels in Patients with Polycystic Ovary Syndrome</title><title>Acta endocrinologica (Bucharest, Romania : 2005)</title><description>ContextInsulin resistance has been detected in a majority of patients with polycystic ovary syndrome (PCOS). Elevated neprilysin levels are associated with insulin resistance. ObjectiveThe present study aims to investigate plasma neprilysin and its relationship with endocrine and metabolic characteristics in patients with PCOS. Subjects and MethodsThirty-five premenopausal PCOS patients and 35 healthy volunteers of similar age were included in the study. Demographic characteristics, biochemical and hormonal findings and also plasma neprilysin levels were determined in these patients and healthy controls. ResultsIn our study, HOMA-IR values were significantly higher in PCOS patients (3.3 ± 1.8) compared with the controls [(1.6 ± 1), p<0.01]. Plasma neprilysin levels were significantly higher in the PCOS group compared to the control group (1502.1 ± 1641.2 vs. 764.6 ± 562.6 pg/mL). There was no difference in plasma neprilysin levels when PCOS patients were classified as overweight-obesity (BMI≥25kg/m2) or non-obesity (BMI<25kg/m2). ConclusionOur findings revealed significantly higher levels for plasma neprilysin and HOMA-IR values in PCOS patients when compared to controls. No significant differences were noted between obese PCOS patients and non-obese PCOS patients in terms of plasma neprilysin levels.</description><subject>General Endocrinology</subject><issn>1841-0987</issn><issn>1843-066X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNpVkF1LwzAYhYMobk6v_AO9FKQzn21yI8iYHzDcQAXvQpK9dZG0nU036b-3c0Pw6j3wHs55OAhdEjzmRLIbA3ZMMaVjJo7QkEjOUpxl78e_mqRYyXyAzmL8xFhITMgpGjChckE5H6LJIphYmuQZ1o0PXfRVMoMthJj0amFaD1Ubk2_frpJFHTrXxda7ZL41TZe8dNWyqUs4RyeFCREuDneE3u6nr5PHdDZ_eJrczVJHpWxTYySQwlLgFGNOwKoiU8AtgwKsNSBySq3gwInLclMIJTOpFMMcS5MT69gI3e5z1xtbwtL1aI0JugcvexxdG6__fyq_0h_1ViuWCU7yPuDqENDUXxuIrS59dBCCqaDeRE1zzDgRTO2s13ura-oYGyj-agjWu9l1P7veza6ZYD_3W3Wr</recordid><startdate>2022</startdate><enddate>2022</enddate><creator>Oz Gul, O</creator><general>Carol Davila University Press</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>2022</creationdate><title>Plasma Neprilysin Levels in Patients with Polycystic Ovary Syndrome</title><author>Oz Gul, O</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c288t-aa8e1fb2e420041eb9f69e4b3efebbae5722b54e41c67af598689930408a71bc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>General Endocrinology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Oz Gul, O</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Acta endocrinologica (Bucharest, Romania : 2005)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Oz Gul, O</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Plasma Neprilysin Levels in Patients with Polycystic Ovary Syndrome</atitle><jtitle>Acta endocrinologica (Bucharest, Romania : 2005)</jtitle><date>2022</date><risdate>2022</risdate><volume>18</volume><issue>1</issue><spage>35</spage><epage>39</epage><pages>35-39</pages><issn>1841-0987</issn><eissn>1843-066X</eissn><abstract>ContextInsulin resistance has been detected in a majority of patients with polycystic ovary syndrome (PCOS). Elevated neprilysin levels are associated with insulin resistance. ObjectiveThe present study aims to investigate plasma neprilysin and its relationship with endocrine and metabolic characteristics in patients with PCOS. Subjects and MethodsThirty-five premenopausal PCOS patients and 35 healthy volunteers of similar age were included in the study. Demographic characteristics, biochemical and hormonal findings and also plasma neprilysin levels were determined in these patients and healthy controls. ResultsIn our study, HOMA-IR values were significantly higher in PCOS patients (3.3 ± 1.8) compared with the controls [(1.6 ± 1), p<0.01]. Plasma neprilysin levels were significantly higher in the PCOS group compared to the control group (1502.1 ± 1641.2 vs. 764.6 ± 562.6 pg/mL). There was no difference in plasma neprilysin levels when PCOS patients were classified as overweight-obesity (BMI≥25kg/m2) or non-obesity (BMI<25kg/m2). ConclusionOur findings revealed significantly higher levels for plasma neprilysin and HOMA-IR values in PCOS patients when compared to controls. No significant differences were noted between obese PCOS patients and non-obese PCOS patients in terms of plasma neprilysin levels.</abstract><cop>Romania</cop><pub>Carol Davila University Press</pub><pmid>35975244</pmid><doi>10.4183/aeb.2022.35</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1841-0987 |
| ispartof | Acta endocrinologica (Bucharest, Romania : 2005), 2022, Vol.18 (1), p.35-39 |
| issn | 1841-0987 1843-066X |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9365417 |
| source | EZB-FREE-00999 freely available EZB journals; PubMed Central |
| subjects | General Endocrinology |
| title | Plasma Neprilysin Levels in Patients with Polycystic Ovary Syndrome |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T06%3A32%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Plasma%20Neprilysin%20Levels%20in%20Patients%20with%20Polycystic%20Ovary%20Syndrome&rft.jtitle=Acta%20endocrinologica%20(Bucharest,%20Romania%20:%202005)&rft.au=Oz%20Gul,%20O&rft.date=2022&rft.volume=18&rft.issue=1&rft.spage=35&rft.epage=39&rft.pages=35-39&rft.issn=1841-0987&rft.eissn=1843-066X&rft_id=info:doi/10.4183/aeb.2022.35&rft_dat=%3Cproquest_pubme%3E2703415397%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2703415397&rft_id=info:pmid/35975244&rfr_iscdi=true |